Latest Gemcitabine Stories
Study Results will be presented at the American Society of Clinical Oncology Annual Meeting in Chicago LONDON, May 14, 2015 /PRNewswire/ -- Immodulon Therapeutics today announced updated
TAIPEI, May 4, 2015 /PRNewswire/ -- PharmaEngine, Inc. (TWO:4162) today announced that its licensing partner, Merrimack Pharmaceuticals, Inc.
Combination Clinical Trial Data Showing Impressive Activity in Bone Cancer and Other Sarcomas LOS ANGELES, May 4, 2015 /PRNewswire/ -- CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical
Updated clinical data presented in an oral session at the 2015 American Association for Cancer Research Annual Meeting CAMBRIDGE, Mass., April 21, 2015 /PRNewswire/ -- Merrimack Pharmaceuticals,
- Note: This press release corresponds to abstract 396 PHILADELPHIA, April 20, 2015 /PRNewswire/ -- Ibrutinib (IMBRUVICA(®)) data presented yesterday by Pharmacyclics, Inc.
Data to support ongoing work with Halozyme's investigational new drug PEGPH20 in combination with immuno-oncology agents SAN DIEGO, April 20, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc.
CALGARY, April 15, 2015 /PRNewswire/ - Oncolytics Biotech(®) Inc. ("Oncolytics") (TSX:ONC) (NASDAQ:ONCY) today announced that Dr.
Recent FDA meeting allows for potential marketing application based on progression free survival in pivotal Phase 3 pancreatic cancer study SAN DIEGO, April 8, 2015 /PRNewswire/ -- Halozyme
CALGARY, March 26, 2015 /PRNewswire/ - Oncolytics Biotech(®) Inc. ("Oncolytics") (TSX:ONC) (NASDAQ:ONCY) today announced that Dr.
--- Significant Survival Benefit Observed in Pre-Specified Subgroups Including Patients with Brain Metastases and Patients with Baseline Liver Metastases --- SAN FRANCISCO, March
- To say in too many words; to express verbosely.
- To express in too many words: sometimes used reflexively.
- The leading idea or a repeated phrase, as of a song or ballad; the refrain; burden.